Circulating levels of cytokines during pregnancy: thrombopoietin is elevated in miscarriage
Objective
To evaluate the hypothesis that cytokine levels are associated with miscarriage risk using serum samples collected before report of miscarriage.
Design
A nested case-control study.
Setting
Biospecimens from the multisite Collaborative Perinatal Project, University of Florida, laboratory assessment of interleukin (IL)-1 receptor antagonist, IL-1β, IL-4, IL-6, interferon (IFN)-γ, tumor necrosis factor (TNF)-α, thrombopoietin (TPO), and granulocyte colony-stimulating factor (G-CSF).
Patient(s)
Cases of miscarriage (n = 439) were matched to controls (n = 373) by gestational age at sample collection.
Intervention(s)
None.
Main Outcome Measure(s)
Miscarriage.
Result(s)
Increased risk of miscarriage was associated with elevated TPO (adjusted odds ratio [OR] 1.16, 95% confidence interval [CI] 1.00–1.36) and decreased G-CSF (adjusted OR 0.78, 95% CI 0.64–0.95). When analysis was restricted to samples collected more than 35 days before miscarriage, the effect of G-CSF was not observed (adjusted OR 0.96, 95% CI 0.72–1.28), whereas increased risk related to higher TPO remained.
Conclusion(s)
Circulating levels of TPO may be associated with increased risk of miscarriage.
Key Words: Cytokines, epidemiology, hematopoiesis, miscarriage, placentation
To access this article, please choose from the options below
Funded by an intramural grant from the Epidemiology Branch of the Division of Epidemiology, Statistics and Prevention Research at the National Institute of Child Health and Human Development.
PII: S0015-0282(07)01214-9
doi:10.1016/j.fertnstert.2007.05.046
© 2008 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

